Intrathecal IgM Synthesis Is Associated with Spinal Cord Manifestation and Neuronal Injury in Early MS.

Authors:
Oechtering J; Lincke T; Schaedelin S; Décard BF; Maceski A and 22 more

Journal:
Ann Neurol

Publication Year: 2022

DOI:
10.1002/ana.26348

PMCID:
PMC9320956

PMID:
35293622

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Ann Neurol

Abbreviation: Ann Neurol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neurology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Circadian Rest-Activity Rhythms, Delirium Risk, and Progression to Dementia.
Gao L; Li P; Gaykova N and 8 more (2023) - Transparency Score: 3/6
Distinct Patterns of Hippocampal Pathology in Alzheimer's Disease with Transactive Response DNA-bin…
Minogue G; Kawles A; Zouridakis A and 12 more (2023) - Transparency Score: 3/6
Regional Analysis of Intact and Defective HIV Proviruses in the Brain of Viremic and Virally Suppre…
Angelovich TA; Cochrane CR; Zhou J and 15 more (2023) - Transparency Score: 3/6
Sports Concussion and Chronic Traumatic Encephalopathy: Finding a Path Forward.
Kelly JP; Priemer DS; Perl DP and 1 more (2023) - Transparency Score: 2/6
5-Year Associations among Cerebral Arterial Pulsatility, Perivascular Space Dilation, and White Mat…
Vikner T; Karalija N; Eklund A and 9 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Potential Conflicts of Interest The authors report no potential conflicts of interests."

Evidence found in paper:

"The authors express their deep thankfulness to patients and relatives for their participation and support, study nurses for their motivated collaboration and recruitment efforts and the administrative personnel of the Swiss Multiple Sclerosis Cohort. This investigation was supported by the Swiss Multiple Sclerosis Society (research grant 2021/10) and Swiss National Science Foundation (grant 320030_189140 / 1). The Swiss MS Cohort study received funding from the Swiss Multiple Sclerosis Society and grant funding from Biogen, Bristol Myers Squibb, Celgene, Merck, Novartis, Roche, and Sanofi. Open access funding provided by Universitat Basel."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025